A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two newly discovered antibodies that also attack the point of communication between nerves and muscle.
- Social media use linked with depression, secondary trauma during COVID-19
- Study reveals dietary fructose heightens inflammatory bowel disease
- Coming soon to a circuit near you
- Vessel noise present year-round at Cordell Bank National Marine Sanctuary
- Many ventilation systems may increase risk of COVID-19 exposure, study suggests